GME vs NAGE · P/E 16, rev $3.63B vs P/E 59, rev $61.3M
GameStop Corp. (GME) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
GameStop Corp. (GME) is a specialty retail company listed on US. It is led by Ryan Cohen.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
GME currently screens at market cap $9.78B and trailing P/E 16.3. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the GME and NAGE stock pages for the full models.
Not investment advice.